Peter J. Feinstein
Director/Board Member at Cylene Pharmaceuticals, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William Rice | M | 65 |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | 21 years |
| Marc Goldberg | M | 67 |
BioVentures Investors
 BioVentures Investors Investment ManagersFinance BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts. | 26 years |
| Daniel Douglas von Hoff | M | 76 |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | 27 years |
| Reinhard Ambros | M | 67 |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | - |
| Charles Bridges | M | - |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts. | - |
| Anthony Lyons | M | - |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts. | 9 years |
| Stephen Liu | M | - |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts. | 8 years |
| Laura Niklason | M | 61 |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts. | - |
| James Lousararian | M | - |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts. | - |
| Walter A. Gilbert | M | 92 |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts. | 23 years |
| Fred Middleton | M | 74 |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | - |
| Donna J. Edmonds | F | - |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts. | - |
| Shaun A. Kirkpatrick | M | - |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | 19 years |
| S. Torres | M | 61 |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | - |
| Jonathan Paull Gertler | M | 67 |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts. | 5 years |
| John E. Osborn | M | 66 |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts. | 6 years |
| Jeffrey T. Barnes | M | 68 |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts. | 14 years |
| Rafael Cordero | M | - |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Andrew C. Freedman | M | - |
New York University
| 7 years |
| Patrick L. Vaccaro | M | - |
New York University
| 12 years |
| Aurora Cassirer | F | 72 |
New York University
| 7 years |
| Kenneth W. Munoz | M | - |
New York University
| 7 years |
| Martin Murphy | M | 81 |
New York University
| 3 years |
| Frank Mastrapasqua | M | 82 |
New York University
| 6 years |
| Samuel G. Weiss | M | 67 |
New York University
| 10 years |
| Jerry M. Seslowe | M | 78 |
New York University
| 8 years |
| Jeffrey D. Saper | M | - |
New York University
| 7 years |
| Joel Dictrow | M | 77 |
New York University
| 7 years |
| Yavuz Altop | M | 85 |
New York University
| - |
| James L. Morice | M | - |
New York University
| - |
| Bill P. Sarubbi | M | - |
New York University
| 4 years |
| Henry W. Sullivan | M | 84 |
New York University
| 4 years |
| Louis E. Black | M | - |
New York University
| 7 years |
| Philip H. Werner | M | - |
New York University
| 4 years |
| James L. Bailey | M | 78 |
New York University
| 1 years |
| Gene Josephs | M | - |
New York University
| 2 years |
| Anthony A. Cella | M | - |
New York University
| 1 years |
| Earl Nemser | M | 77 |
New York University
| 4 years |
| Judah C. Sommer | M | - |
New York University
| 3 years |
| Paul J. Tagliabue | M | 84 |
New York University
| 3 years |
| Sanford B. Ehrenkranz | M | - |
New York University
| 3 years |
| George M. Weiss | M | 81 |
New York University
| 5 years |
| Richard M. Kessel | M | - |
New York University
| 4 years |
| William Berkley | M | 78 |
New York University
| 4 years |
| Stephen Barnett | M | - |
New York University
| 4 years |
| Martin Sanford Roher | M | 74 |
New York University
| 3 years |
| Gabriel B. Jaffe | M | - |
New York University
| 3 years |
| Naomi L. C. Luban | M | - |
New York University
| 3 years |
| Rick Harris | M | - |
New York University
| 4 years |
| Dennis J. Rosen | M | 77 |
New York University
| 3 years |
| Maryann Zimmer | F | 72 |
New York University
| 4 years |
| John Raymont | M | - |
New York University
| 4 years |
| Dee A. Replogle | M | - |
New York University
| 3 years |
| Adam Blumenstein | M | 77 |
New York University
| 4 years |
| Bruce W. Sanford | M | - |
New York University
| 3 years |
| Myron Bari | M | - |
New York University
| 1 years |
| Joseph J. Jamin | M | - |
New York University
| 4 years |
| James R. Gottlieb | M | 76 |
New York University
| 1 years |
| William Oliver Stone | M | 77 |
New York University
| 4 years |
| Rudolph W. Giuliani | M | - |
New York University
| 4 years |
| Walter F. Raquet | M | 77 |
New York University
| 4 years |
| Gregory D. Frost | M | 76 |
New York University
| 4 years |
| Dana P. Sidur | F | - |
New York University
| 4 years |
| Roger O. Goldman | M | 79 |
New York University
| 4 years |
| Van Schreiber | M | 84 |
New York University
| 2 years |
| Stephen Getsy | M | 78 |
New York University
| 5 years |
| Christopher M. Miner | M | 72 |
New York University
| 4 years |
| Gerald Howard Lipkin | M | 82 |
New York University
| 2 years |
| David A. Florman | M | 71 |
New York University
| 4 years |
| Jennifer C. Dolan | F | 77 |
New York University
| 2 years |
| Michael A. Gibbs | M | 87 |
New York University
| 1 years |
| Michael C. Markovitz | M | 70 |
New York University
| 4 years |
| Philip Cottone | M | 84 |
New York University
| 3 years |
| H. Dale Hemmerdinger | M | 79 |
New York University
| 4 years |
| Mitchell S. Landis | M | 73 |
New York University
| 4 years |
| Lawrence A. Zimmerman | M | 81 |
New York University
| 4 years |
| Paul M. Ness | M | 78 |
New York University
| 3 years |
| Michael T. Bebon | M | - |
New York University
| 4 years |
| Mark Leslie | M | 77 |
New York University
| 4 years |
| Linda Ruth Killian | F | - |
New York University
| 4 years |
| Ed Sullivan | M | - |
New York University
| 1 years |
| Evan Chesler | M | - |
New York University
| 4 years |
| William H. Purcell | M | - |
New York University
| 4 years |
| Simon Stertzer | M | 88 |
New York University
| 18 years |
| Thomas Sidlik | M | 73 |
New York University
| 4 years |
| Dale Winston | F | - |
New York University
| 4 years |
| Andrew Radding | M | - |
New York University
| 4 years |
| John B. Poindexter | M | - |
New York University
| 2 years |
| Dick L. Sherman | M | 76 |
New York University
| 3 years |
| Michael B. Hopkins | M | - |
New York University
| 4 years |
| Bill Leach | M | - |
New York University
| 4 years |
| Paul J. Konigsberg | M | 87 |
New York University
| 3 years |
| Harold M. Levine | M | - |
New York University
| 2 years |
| Hans Sandberg | M | 78 |
New York University
| 3 years |
| Ron L. Strauss | M | - |
New York University
| 2 years |
| Edward Ernst Dohrmann | M | - |
New York University
| 2 years |
| Donald E. Bradley | M | - |
New York University
| 3 years |
| Candace Beinecke | F | 76 |
New York University
| 4 years |
| John Joseph Murphy | M | 80 |
New York University
| 4 years |
| William Edward Crystal | M | 76 |
New York University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peter J. Feinstein
- Personal Network
